Nordic Capital has expanded its healthcare team with the addition of Dr Raj Shah who joins as Partner in the London office.
Prior to joining, Dr Shah was Co-Head of EMEA Healthcare Investment Banking at Goldman Sachs International and he joins as Nordic Capital continues to expand its world-leading healthcare investment practice.
Dr Shah, a former cardiac surgeon, joined Goldman Sachs over a decade ago and has in recent years co-led the team that has been involved in several pivotal transactions that have helped shape the healthcare landscape, including Nordic Capital’s successful exit of specialty pharmaceutical firm Nycomed through a sale to Takeda for EUR 9.6bn in 2011.
“For the past 20 years, Nordic Capital has been a frontrunner in European healthcare investments. Raj has highly relevant senior level competence and experience and is a great addition to our team, as we see continued significant opportunities in global healthcare,” says Kristoffer Melinder, Co-Managing Partner, NC Advisory AB, advisor to the Nordic Capital Funds.
“I have known and worked with Raj for many years. He is highly regarded in the healthcare industry and the investment community. Nordic Capital has strong commitment to the sector as demonstrated by our ability to attract and execute this senior level appointment,” says Toni Weitzberg, Partner, NC Advisory AB, advisor to the Nordic Capital Funds.
Dr Shah will be based in London at NC Advisory (UK) LLP, advisor to the Nordic Capital Funds with a view to further expanding its global healthcare advisory team.
Nordic Capital’s healthcare team includes Partners Toni Weitzberg, Kristoffer Melinder, Fredrik Näslund and Jonas Agnblad. The Nordic Capital Funds have invested in 17 healthcare companies over the years; accounting for c. 40% of aggregate invested capital. Current and previous Nordic Capital investments within the healthcare sector include leading global companies such as Nycomed, ConvaTec, Capio, Permobil, Mölnlycke Health Care, Fougera, Binding Site and Atos Medical.
